By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) -Shares in Novo Nordisk fell as much as 3.5% on Monday after ...

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

The nine worst affected areas are predicted to see rates rise above 50 per cent by 2035, meaning the majority of children ...

“The medication comes with a patient information leaflet listing common side effects, including feeling sick, indigestion, ...

Projections show half of ten and 11-year-olds could be overweight or obese in some areas, with experts calling for urgent ...

Patients who took a lower dose lost more weight on average. Read more at straitstimes.com. Read more at straitstimes.com.

Ecnoglutide is a GLP-1 receptor agonist, part of a growing class of drugs that help control blood sugar and reduce hunger.

Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...

The Fit Kitchen Workshop, established by the Gaziantep Metropolitan Municipality, southeastern Türkiye, as part of its ...

Novo Nordisk’s next-gen weight loss drug and Zepbound “seem fairly equal to me,” one expert says after release of new ...

Nearly 1 in 4 people have sarcopenic obesity, a dangerous condition mixing muscle loss and weight gain. Learn the warning signs and prevention tips.

Prescriptions for Mounjaro jabs, to help people lose weight, will be available at GP surgeries in England from today - but ...